Garcia's Thoracic Outlet Evaluation Signals Extended Blue Jays Bullpen Uncertainty

Yimi Garcia is heading for evaluation on thoracic outlet syndrome, per Sportsnet, marking another complication in what has been a protracted comeback for the Blue Jays right-hander. The reliever reported neck discomfort during his minor-league rehab assignment, prompting the organization to investigate whether a vascular condition is limiting his return timeline. For a team already thin in the bullpen, the news adds friction to an already compressed recovery schedule.

Garcia's original injury—elbow surgery—sidelined him for over a year. That timeline alone is substantial enough to warrant caution. The detection of neck discomfort during rehab, however, suggests the underlying biomechanical or vascular constraint may run deeper than the initial elbow repair. Thoracic outlet syndrome, which can restrict blood flow and nerve function to the arm and shoulder, is particularly problematic for pitchers because it directly compromises the mechanics and durability of the throwing shoulder. If confirmed, it could extend his absence further and potentially limit his velocity or capacity to handle high-leverage innings even after clearance to pitch.

Toronto's bullpen depth is already a leverage point in games where they're protecting leads late. Without Garcia available, the team leans more heavily on a smaller core of relievers in critical spots. This concentrates workload—and fatigue—across fewer arms heading into August and September. For bettors, the practical effect is narrower bullpen flexibility in close games, which historically correlates with higher volatility in team total outcomes and slightly elevated unders in tight contests.

The key prop angle here is team total volatility rather than directional plays on individual Garcia performance. If Garcia remains unavailable and Toronto's bullpen depth compresses further, late-game leverage situations become more predictable: the same relievers will shoulder higher inning counts and higher-stress moments. This can suppress run-scoring variance in the seventh inning onward, because depth-limited bullpens often lean conservative with leads. That's not a guarantee unders cash—a strong offensive lineup can still drive runs—but it does increase the proportion of games where Toronto's ceiling (in close contests) is constrained by bullpen capacity rather than hitting performance. Team totals at 4.5 or 5.0 runs become slightly more attractive on the under in games where Garcia's absence is meaningful to in-game construction.

The evaluation itself is the critical threshold. If TOS is ruled out, the timeline normalizes and Garcia re-enters the bullpen equation sooner. If confirmed, Toronto faces another rehab protocol and a deeper loss of innings in the second half. Either way, the decision window is narrow—teams with playoff ambitions can't afford extended opacity in their depth picture.